Why it was recalled
Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Product description
Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90
Lot numbers, UPCs & expiration codes
Lot #s: 2436144, 2436582, 2441567, 2441568, Exp 08/31/2014.
Where it was sold
Nationwide and PR
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-070-2013
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Nov 9, 2012
- FDA report date
- Dec 5, 2012
- Quantity
- 120,201 Bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Ranbaxy Inc.
Original FDA data
Every field from FDA enforcement report D-070-2013, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 63759
- Address
- 600 College Rd E Ste 2100
- Code information
- Lot #s: 2436144, 2436582, 2441567, 2441568, Exp 08/31/2014.
- Postal code
- 08540-6636
- Report date
- Dec 5, 2012
- Product type
- Drugs
- Recall number
- D-070-2013
- Classification
- Class II
- Recalling firm
- Ranbaxy Inc.
- Product quantity
- 120,201 Bottles
- Termination date
- Apr 28, 2014
- Reason for recall
- Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90
- Distribution pattern
- Nationwide and PR
- Recall initiation date
- Nov 9, 2012
- Initial firm notification
- Letter
- Center classification date
- Nov 29, 2012